Sign in to view content

Phase III Randomized Clinical Trial Comparing SB15 With Reference Aflibercept in Neovascular Age-Related Macular Degeneration 56-Week Results

Min Sagong, MD

Video
Published 2023

Related

COAST: A Phase 3 Study of Intravitreal Sozinibercept Combined With Aflibercept in Participants With Neovascular Age-Related Macular Degeneration
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2025
Safety Profiles of Combined Anticomplement and Anti-VEGF Intravitreal Therapies for Age-Related MacularDegeneration From Real-World Data
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2025
Comparison of Originator and Biosimilar Medications for Pediatric Noninfectious Uveitis
Nita Valikodath, MD, MS
Annual Meeting Talks
2023

Category: AMD-Neovascular

See more